A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.


Phase 4 Results N/A

Summary of Purpose

The aim of this study is to evaluate the safety of Ginkgolides Meglumine Injection in the treatment of ischemic stroke with Syndrome of Intermingled Phlegm and Blood Stasis.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 December 2014.

1 Jun 2013 29 Sep 2013 1 Oct 2014 1 Oct 2014 1 May 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


Not available